baber/WOPTO huggingface dataset:
Patent AU-2020365094-A1 (AU)
Title: Constant velocity coupling
Inventor: PARKER SIMON
IPC: F16D3/42
Filed: 2020-10-08
Abstract: A constant velocity joint comprising two concentric couplings (1, 2), a first coupling (1) comprising an inner member (211), an intermediate annular member (221) and an outer annular member (231), the members being concentric. The inner member (231) of the second coupling (2) is common to the outer member (231) of the first coupling (1). The members of the couplings are constrained to rotate one with respect to another and the outer member of the second coupling is constrained to rotate angularly in respect of the common member in a way that is the mirror image of the rotation of the inner member with respect to the common member.
Patent AU-2020395089-A1 (AU)
Title: Apparatus, system and method for lifting a conveyor belt
Inventor: WHEELER CRAIG ANTHONY
IPC: G01G11/00
Filed: 2020-12-02
Abstract: An apparatus (10) adapted to lift a conveyor belt (12) relative to a supporting structure (14). The apparatus (10) includes a cradle (16) adapted to support the conveyor belt (12), a base arrangement (17) adapted to locate with the supporting structure (14) and a lifting mechanism (20) operatively coupled between the base arrangement (17) and the cradle (16) so that the conveyor belt is elevatable in a supported condition. The apparatus including a load sensor arrangement (22) configured to measure a load carried by the apparatus associated with lifting the belt. A system (100) including the apparatus (10) and method are also disclosed
Patent AU-2020423601-A1 (AU)
Title: Lipid nanoparticles for in-vivo drug delivery, and uses thereof
Inventor: LEE HYUKJIN
IPC: A61K48/00
Filed: 2020-12-31
Abstract: The present invention relates to lipid nanoparticles for in-vivo drug delivery and to uses thereof, wherein the lipid nanoparticles are specific to liver tissue, have excellent biocompatibility, and can deliver, with high efficiency, a gene therapeutic agent, etc., and thus can be utilized in related technical fields such as lipid nanoparticle-mediated gene therapy, etc.
Patent AU-2020478543-A1 (AU)
Title: Anticorrosive coating composition
Inventor: LIM ANDREW
IPC: C09D5/08
Filed: 2020-11-30
Abstract: There is provided an anticorrosive coating composition comprising an epoxy ester resin and a non-leafing grade aluminium pigment.
Patent AU-2021200774-A1 (AU)
Title: Total joint replacement infection control devices and methods
Inventor: ARNOLD BENJAMIN
IPC: A61F2/30
Filed: 2021-02-07
Abstract: An orthopedic system for delivery of a therapeutic agent to a bone includes an 
elongate stem adapted to be inserted into an intramedullary canal, an inlet configured to 
receive the therapeutic agent, and one or more outlets configured to deliver the therapeutic 
agent to the bone. The elongate stem may comprise one or more protrusions to engage the 
bone, and one or more channels extending longitudinally therein, fluidly coupled to the inlet.  
The therapeutic agent flows from the inlet through the one or more channels and exits into the 
intramedullary canal through the one or more outlets. The system may be configured to 
allow one or more dimensions of the system to be adjusted to accommodate the anatomy of a 
patient.
WO 2016/205077 PCT/US2016/036761 
1/38 
100 
100 
110 
110 13 
132a 
105 ' 132b 
* 132 
1200 
FIG.l1A FIGl1B
Patent AU-2021201426-A1 (AU)
Title: Systems and methods for control of a remotely controllable material handling vehicle
Inventor: GARRISON III THEODORE C
IPC: G05D1/00
Filed: 2021-03-04
Abstract: The invention proposes a remotely controllable material handling vehicle switchable between a manual mode and a travel 
request mode, the system comprising: a control handle controlling a speed and direction of the material handling vehicle 
when the material handling vehicle is in the manual mode; a remote control device in communication with the material 
handling vehicle and configured to provide a request to the material handling vehicle to move forward; a mode switch 
switching the material handling vehicle from the manual mode to the travel request mode; and an operator compartment 
sensor triggering a flag when a weight on a floor of an operator compartment of the material handling vehicle is greater than 
or equal to a predetermined weight, wherein when the material handling vehicle is in the travel request mode the operator 
compartment sensor is removed from communication with the material handling vehicle.
3/5 
LO C14 
0 ZD 
U) 
CO 0 
0 ca 
ca 0 a) 0 
o C) - - C) U) 
a) cf) 
U) CO a) oc) 
=3 a) 0 C7= a) o ca 
(Do 
ca 
C=) 
CD C14 
LO LO Z5 ca A.&- -- U) 
a) ca = 0- 0- a) 
> 0 0 F= CO LL.  
a) ---------- 0 0 C-0 C) a) 
_j 00 
CD cy') 
CD CD 
C14 
cy') 
0 :t-f 2 C) E > U) 
0 in > 
E m 4) ;t C-0 C\j C\j 
C\j C\j 
CD C\j
Patent AU-2021204664-A1 (AU)
Title: Automatic Robotic And Manual Medical Device Capsule To Aid Self Healing
Inventor: GRBIN DARREN
IPC: A61N5/06
Filed: 2021-07-04
Abstract: A capsule device comprising a glass dome lid, a fixed base and air vents arranged on the sides of the 
capsule. A mattress and a pillow are arranged on the surface of the fixed base to receive a person. The 
glass dome lid uses natural and solar powered lighting to emit a different coloured light beam onto the 
bodies seven chakra centres.
Patent 
The capsule can be operated from inside and outside. The dome can open & close 
automatically at the push of A button through an electronic sensor or it can open and close 
manually from inside or outside for ease of movement.  
Elevation 
Base Of Capsule Mattress Pillow 
Glass Dome Lid AirVents 
DNG Page 4/4
Patent AU-2021207626-A1 (AU)
Title: Repeated administration of dihydroergotamine for treatment of frequent migraine headaches
Inventor: HOEKMAN JOHN D
IPC: A61K31/4985
Filed: 2021-01-13
Abstract: Methods are provided for reducing the frequency of migraine attacks in a subject who has frequent migraine headaches with or without aura. The methods comprise intranasally administering to the subject a pharmaceutical composition comprising dihydroergotamine (DHE) or salt thereof on a repeat dose schedule, wherein each intranasal administration is delivered by a manually actuated, propellant-driven, metered-dose administration device, and wherein the schedule is a chronic intermittent schedule in which each of the repeated administrations is performed while the subject is experiencing a migraine headache.
Patent AU-2021210823-A1 (AU)
Title: Digital microfluidic (DMF) system, DMF cartridge, and method including integrated optical fiber sensing
Inventor: IYER KRISHNA
IPC: G01N21/01
Filed: 2021-01-20
Abstract: A cartridge for use with an instrument to perform measurement of a fluid, including a digital microfluidics substrate comprising a plurality of electrowetting electrodes operative to perform droplet operations on a liquid droplet in a droplet operations gap; a top plate separated from the digital microfluidics substrate to form a droplet operations gap and comprising openings for injecting liquids into the droplet operations gap; a fiber assembly comprising a fiber optic probe projecting into the droplet operations gap and having a sensing end situated in proximity with one or more of the electrowetting electrodes.
Patent AU-2021214166-A1 (AU)
Title: Peptide immunogens targeting PCSK9 and formulations thereof for prevention and treatment of PCSK9-mediated disorders
Inventor: WANG CHANG YI
IPC: A61K39/08
Filed: 2021-01-28
Abstract: The present disclosure is directed to peptide immunogen constructs targeting the catalytic domain of the PCSK9 protein, compositions containing the constructs, antibodies elicited by the constructs, and methods for making and using the constructs and compositions thereof. The disclosed peptide immunogen constructs have more than about 20 amino acids and contain (a) a B cell epitope having about more than about 7 contiguous amino acid residues from the PCSK9 and LDL-R receptor binding regions of the catalytic domain of the PCSK9 protein; (b) a heterologous Th epitope; and (c) an optional heterologous spacer. The disclosed PCSK9 peptide immunogen constructs stimulate the generation of highly specific antibodies directed to PCSK9 sites that are binding to LDL-R to allow for the prevention and/or treatment of patients with PCSK9 mediated disorders including an increased serum level of low-density lipoprotein cholesterol (LDL-C) and CV events.
Patent AU-2021218027-A1 (AU)
Title: Beverage dispensing systems and methods
Inventor: APONE DAN
IPC: A47J31/44
Filed: 2021-08-17
Abstract: BEVERAGE DISPENSING SYSTEMS AND METHODS 
ABSTRACT OF THE DISCLOSURE 
Various beverage preparation systems and methods are disclosed. The beverage 
preparation system can include a dispensing unit configured to receive beverage, such as a shot 
of espresso, from a beverage preparation machine. The dispensing unit can include a 
dispensing unit with a first end and a second end. The dispensing unit can be rotatable between 
an upright position and an inverted position. The dispensing unit can be configured to receive 
the beverage through the second end when the dispensing unit is in the upright position, and 
can be configured to receive cleansing fluid through the second end when the dispensing unit 
is in the inverted position. In some embodiments, when the dispensing unit is in an intermediate 
position between the upright and inverted positions, the dispensing unit is configured to 
dispense the beverage out of the first end and into a cup or other vessel.
Patent AU-2021219991-A1 (AU)
Title: Process for preparing S-beflubutamid by resolving 2-bromobutanoic acid
Inventor: CORBETT RICHARD M
IPC: C07C51/43
Filed: 2021-02-10
Abstract: Disclosed is a method for preparing compound S-1 (S-1) comprising resolving compound rac-2 (rac-2) with a compound of Formula 3 wherein R
Patent AU-2021222388-A1 (AU)
Title: Actuation unit and valve assembly comprising the same
Inventor: WILKINSON RUPERT
IPC: F16K31/56
Filed: 2021-02-17
Abstract: A valve assembly including a valve arranged to move between an open position and a closed position by rotating an operating member of the valve about an axis. An actuation unit (16) comprises a torsion spring (34), a trigger member (20), and a driving member (36). The driving member (36) engages with the operating member of the valve to drive rotation of the operating member. The torsion spring (34) applies a first torque to the driving member around the axis in a first rotational direction. An external second torque applied opposite to the first torque resets the valve to the open position in which the driving member (36) is held by a latching mechanism. The latching mechanism is arranged to hold the driving member only when the valve is in the open position. An external force applied to the trigger member (20) releases the driving member (36) from the latching mechanism, the first torque thereby rotating the driving member (36) to mechanically bias said valve to the closed position.
Patent AU-2021228737-A1 (AU)
Title: Identifying methylation patterns that discriminate or indicate a cancer condition
Inventor: MELTON COLLIN
IPC: G16B30/00
Filed: 2021-02-26
Abstract: Systems and methods of identifying methylation patterns discriminating or indicating a cancer condition are provided. First and second datasets are obtained. Each dataset comprises a plurality of fragment methylation patterns determined by methylation sequencing of nucleic acids obtained from a first or second set of subjects and comprising a methylation state of each CpG site in a corresponding plurality of CpG sites. Each plurality of subjects has a respective first or second state of the cancer condition. First and second interval maps are generated for each respective dataset, each comprising a plurality of nodes characterized by a start methylation site, an end methylation site, a representation of each different fragment methylation pattern and a count of fragments. The first and second interval maps are scanned for qualifying methylation patterns within a predetermined range of CpG sites, satisfying one or more selection criteria, thereby identifying methylation patterns discriminating a cancer condition.
Patent AU-2021237987-A1 (AU)
Title: N-acylhydrazonic compounds, use in the treatment of amyloid and non-amyloid degenerative aggregopathies, and pharmaceutical composition
Inventor: ADRIÁN REY NICOLÁS
IPC: A61P27/12
Filed: 2021-03-15
Abstract: The present invention relates to a family of N-acyl-hydrazone compounds structurally derived from 1-methyl-1H-imidazole-2-carboxaldehyde, or pharmaceutically acceptable salts thereof, and to the use of said compounds for preventing and/or treating amyloid degenerative aggregopathies (such as Alzheimer's disease, Parkinson's disease and type 2 diabetes) and non-amyloid degenerative aggregopathies (such as cataracts). Said compounds act as attenuators of metal-protein interactions, preventing and/or decreasing protein oligomerization by competing with the target peptide or protein for binding to physiological metal ions, and possibly by modulating the protein-protein interactions per se. The invention also relates to four compounds specifically described as examples of N-acyl-hydrazones derived from 1-methyl-1H-imidazole-2-carboxaldehyde, namely: 1-methyl-1H-imidazole-2-carboxaldehyde isonicotinoyl hydrazone, 1-methyl-1H-imidazole-2-carboxaldehyde benzoyl hydrazone, 1-methyl-1H-imidazole-2-carboxaldehyde 2-furoyl hydrazone and 1-methyl-1H-imidazole-2-carboxaldehyde 2-thiophenyl hydrazone. The present application also comprises pharmaceutical compositions.
Patent AU-2021240127-A1 (AU)
Title: Gaming device with mystery configurable symbols
Inventor: SIDOTI ALESSANDRO
IPC: A63F13/25
Filed: 2021-09-27
Abstract: A gaming device comprises a display, a random number generator, a processor, and 
a memory storing instructions. When the instructions are executed by the processor, 
they cause the processor to conduct a base game by configuring reel strips for the 
base game by selecting for each configurable symbol of the reel strips, an indicator to 
form part of the respective configurable symbol upon the configurable symbol being 
displayed, wherein each indicator is selected from a plurality of prize value indicators 
and a mystery prize indicator using the random number generator, selecting, using the 
random number generator, symbols from the configured reels strips for a plurality of 
symbol positions of a first game window, and controlling the display to display the 
selected symbols at the plurality of symbol positions in the first game window. The 
instructions cause the processor to trigger a feature game upon the selected symbols 
including a threshold number of configurable symbols, and conduct the feature game 
by controlling the display to display a plurality of game windows including the first 
game window, replicating the triggering configurable symbols of the first game window 
at corresponding symbol positions in each other game window, upon the replicated 
triggering configurable symbols including one or more configurable symbols with a 
mystery indicator, revealing prize value indicators determined using the random 
number generator for each configurable symbol with a mystery indicator and each 
replicated configurable symbol with a mystery indicator, conducting, until an end 
condition is met, game instances in which further configurable symbols may be 
selected at one or more symbol positions not already occupied by a configurable 
symbol, and making an award of at least the prizes indicated by the prize value 
indicators in each active game window of the plurality of game windows.
605 
570 
Counter = N 
610 
Hold COR symbols 
615 
Associate Reels with Symbol 
Positions 
620 
Configure Reels with COR 
Values 
625 
Select from Reel Strips and 
Display 
630 6406 
New COR N Counter = Counter 
Symbol? Counter -1 =0? 
Y y 650 
655 660 
N All yAward END 
positions Jackpot 
full? 
FIG. 6
Patent AU-2021240303-A1 (AU)
Title: Production cell line enhancers
Inventor: CHEN GANG
IPC: C12N15/79
Filed: 2021-10-01
Abstract: The present invention relates to discovery of the ectopic expression of EDEM2 in a 
production cell to improve the yield of a useful multi-subunit protein. Thus, the present 
invention provides for production cell lines, such as the canonical mammalian 
biopharmaceutical production cell - the CHO cell, containing recombinant polynucleotides 
encoding EDEM2. Also disclosed is a production cell containing both an EDEM2-encoding 
polynucleotide as well an XBP1-encoding polynucleotide. Improved titers of antibodies 
produced by these cell lines are disclosed, as well as the improved cell densities attained by 
these cells in culture.  
25
Patent AU-2021242355-A1 (AU)
Title: Molecules for organelle-specific protein delivery
Inventor: BETTOUN JOAN DAVID
IPC: A61P25/28
Filed: 2021-03-26
Abstract: The present disclosure provides a fusion protein useful for treating a non-nuclear organelle associated disorder, such as a genetic disorder,
Patent AU-2021243727-A1 (AU)
Title: Method for playing on a player of a client device a content streamed in a network
Inventor: YOUSEF HIBA
IPC: H04N21/25
Filed: 2021-03-25
Abstract: The present invention relates to a method for playing on a player of a client device (11) a content streamed in a network (1), said content consisting of a sequence of segments available in a plurality of quality levels, the player being configured so as to choose the quality level of the segments as a function of at least one parameter representative of a segment reception rate, according to an Adaptive BitRate, ABR, logic of the player; the client device (11) comprising a first buffer (M1) for storing segments in a format adapted for transferring within the network (1), the method being characterized in that it comprises performing by a processing unit (110) of the client device (11): (a) receiving from the player a request for a current segment at a first quality level; (b) determining that the player will request according to its ABR logic a next segment at a second quality level after said requested current segment is provided from the first buffer memory (M1), using a model predicting the ABR logic of the player; (c) if said next segment is not present at said second quality level in the first buffer memory (M1), fetching said next segment at said second quality level from the network (1).
Patent AU-2021250868-A1 (AU)
Title: Combination pillow and sleeping bag or blanket or comforter
Inventor: SUTTON JOSEPH A
IPC: A47G9/08
Filed: 2021-10-12
Abstract: A combination pillow and sleeping bag is described. The combination pillow and 
sleeping bag is configurable between a first configuration and a second configuration. The 
combination pillow and sleeping bag includes a first pillow portion and a second pillow 
portion detachably coupled to the first pillow portion. The second pillow portion defines a 
cavity. The combination pillow and sleeping bag also includes a sleeping bag having a first 
end coupled to the first pillow portion and a second end coupled to the second pillow portion.  
When in the first configuration, the first and second pillow portions are coupled together and 
the sleeping bag is positioned within the cavity of the second pillow portion. When in the 
second configuration, the first and second pillow portions are detached from one another and 
spaced apart such that the sleeping bag extends between the first and second pillow portions.  
28 
18150783_1 (GHMatters) P115681.AU.1
Patent AU-2021257884-A1 (AU)
Title: Multimodal device for transdermal treatments
Inventor: SMITH ANDRÉ HUGO
IPC: A61G10/02
Filed: 2021-10-25
Abstract: OF THE INVENTION 
The present invention includes an apparatus for transdermal treatments comprising: an openable 
enclosure for a subject in communication with three or more sources of treatment modalities 
selected from: a source of ozone; a source of steam, a source of C02 / Carbonic Acid; a source 
5 of Far Infrared; and a source of pulsed electromagnetic fields (PEMF), wherein each of the three 
or more sources is in communication with an interior of the openable enclosure to treat the 
subject transdermally.
Patent AU-2021259852-A1 (AU)
Title: (S)-2-amino-6-((3-aminopropyl)amino)hexanoic acid (APL) for use in the treatment of non-alcoholic steatohepatitis (NASH), liver inflammation, hepatocellular ballooning, liver fibrosis and steatosis
Inventor: MERALI SALIM
IPC: A61K31/198
Filed: 2021-04-23
Abstract: (S)-2-amino-6-((3-aminopropyl)amino)hexanoic acid (APL) for use in the treatment of non-alcoholic steatohepatitis (NASH), liver inflammation, hepatocellular ballooning, liver fibrosis and steatosis.
Patent AU-2021277608-A1 (AU)
Title: Compositions and methods for vas-occlusive contraception and reversal thereof
Inventor: HERR JOHN C
IPC: A61F6/22
Filed: 2021-11-29
Abstract: Disclosed are methods of delivering an agent to the lumen of the vas deferens under guidance 
of ultrasound imaging. The methods include vas-occlusive contraception in which the vas 
deferens is non-surgically isolated and an occlusive substance is percutaneously 
administered into the lumen of the vas deferens under ultrasound. Also disclosed are 
methods of reversal of vas-occlusive contraception and methods of delivering an agent to 
the lumen of the vas deferens. Also disclosed are compositions for use in the methods of the 
invention.
Patent AU-2021277637-A1 (AU)
Title: Respiratory mask with nasogastric tube path
Inventor: LIM JAE YUN
IPC: A61M16/06
Filed: 2021-11-30
Abstract: RESPIRATORY MASK WITH NASOGASTRIC TUBE PATH 
ABSTRACT OF THE DISCLOSURE 
A respiratory mask can be used to provide therapy to patients who also require a 
nasogastric (NG) tube. The mask seal can include a path that is designed to deform around 
an NG tube or other without lifting the mask away from a patient's face. The deforming path 
can help to minimize gaps that form between the patient's face and the mask seal as a result 
of the tube, thus reducing leaks and improving the efficacy of the treatment.  
-24-
Patent AU-2021282475-A1 (AU)
Title: System-aided method to structure and formulate adaptive tutorial sessions
Inventor: HAU KITTY KIT KING
IPC: G06F15/00
Filed: 2021-12-08
Abstract: The present invention relates to a method to keep teachers informed of students' 
performance and learning behaviour and be involved in the process of offering in time 
5 extra support to slower performers to take Tutorial Sessions structured and formatted 
by the system to meet the slower performers' ability levels and learning needs.
1/23 
-Principal -- CCE ' Go tO Admin 
PASSWORD
FORGET 
SECRET 
QUESTION? 
ID 
SUCCESS TO 
ANSWER 
THE 
QUESTIONS 
FORGEPWTO 
USER 
PROMPTTO 
USER 
Figure 1
Patent AU-2021285843-A1 (AU)
Title: Systems and method for intent messaging
Inventor: SALTER JEFFREY
IPC: H04M3/523
Filed: 2021-06-02
Abstract: Disclosed embodiments provide a framework to assist customers in obtaining relevant responses from brands and other users to the intents communicated by these customers. In response to obtaining an intent, an intent messaging service identifies one or more users that can be provided with the intent to solicit responses to the intent. The one or more users are selected based on characteristics of the intent. The intent messaging service evaluates the responses to the intent from the one or more users to identify relevant responses that can be presented to the customer. The intent messaging service provides the relevant responses to the intent to the customer, which can determine which users to interact with to address the intent.
Patent AU-2021333461-A1 (AU)
Title: Washing appliance
Inventor: BLAIR DANIEL WARWICK
IPC: D06F39/12
Filed: 2021-08-25
Abstract: A drawer for a washing apparatus includes a metal material tub, a metal material bracket attached to an exterior of the tub, and a plastic material flange connected to the bracket. The flange may be connected to an upper section of the bracket. The flange may be connected to the bracket by inserting a connector through the bracket and into the flange.